NUSAP1 and glioblastoma: Furthermore, VEGFA 26, known to hinder tumor immunotherapy, demonstrated a positive correlation with the expression levels of NUSAP1 in GBM, KICH, KIRC, KIRP, LUAD, PAAD, SARC, and SKCM.